{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:08:56Z","timestamp":1793333336136,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,9,14]],"date-time":"2017-09-14T00:00:00Z","timestamp":1505347200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alpe d'Huzes Foundation (Dutch Cancer Society)","award":["UM 2013-6229"],"award-info":[{"award-number":["UM 2013-6229"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1007\/s00259-017-3823-0","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T19:28:26Z","timestamp":1505330906000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":32,"title":["Added value of dedicated axillary hybrid 18F-FDG PET\/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6431-3538","authenticated-orcid":false,"given":"Thiemo J. A.","family":"van Nijnatten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Goorts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"V\u00f6\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. F. S.","family":"Kooreman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. M.","family":"Heuts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. E.","family":"Wildberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. M.","family":"Mottaghy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. B. I.","family":"Lobbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. L.","family":"Smidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,9,14]]},"reference":[{"key":"3823_CR1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","volume":"65","author":"LA Torre","year":"2015","unstructured":"Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87\u2013108. \nhttps:\/\/doi.org\/10.3322\/caac.21262\n\n.","journal-title":"CA Cancer J Clin"},{"key":"3823_CR2","unstructured":"Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds). SEER Cancer Statistics Review, 1975\u20132013, National Cancer Institute. Bethesda, MD, \nhttp:\/\/seer.cancer.gov\/csr\/1975_2013\/\n\n, based on November 2015 SEER data submission, posted to the SEER website, April 2016."},{"issue":"Suppl 5","key":"3823_CR3","doi-asserted-by":"publisher","first-page":"v8","DOI":"10.1093\/annonc\/mdv298","volume":"26","author":"E Senkus","year":"2015","unstructured":"Senkus E, Kyriakides S, Ohno S, Penault-Llorca F, Poortmans P, Rutgers E, et al. Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2015;26(Suppl 5):v8\u201330. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdv298\n\n.","journal-title":"Ann Oncol"},{"key":"3823_CR4","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1245\/s10434-011-2108-2","volume":"19","author":"M Kaufmann","year":"2012","unstructured":"Kaufmann M, von Minckwitz G, Mamounas EP, Cameron D, Carey LA, Cristofanilli M, et al. Recommendations from an international consensus conference on the current status and future of neoadjuvant systemic therapy in primary breast cancer. Ann Surg Oncol. 2012;19:1508\u201316. \nhttps:\/\/doi.org\/10.1245\/s10434-011-2108-2\n\n.","journal-title":"Ann Surg Oncol"},{"key":"3823_CR5","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1016\/j.breast.2013.09.002","volume":"22","author":"RJ Schipper","year":"2013","unstructured":"Schipper RJ, van Roozendaal LM, de Vries B, Pijnappel RM, Beets-Tan RG, Lobbes MB, et al. Axillary ultrasound for preoperative nodal staging in breast cancer patients: is it of added value? Breast. 2013;22:1108\u201313. \nhttps:\/\/doi.org\/10.1016\/j.breast.2013.09.002\n\n.","journal-title":"Breast"},{"key":"3823_CR6","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/j.ejrad.2016.10.030","volume":"85","author":"TJ Nijnatten van","year":"2016","unstructured":"van Nijnatten TJ, Ploumen EH, Schipper RJ, Goorts B, Andriessen EH, Vanwetswinkel S, et al. Routine use of standard breast MRI compared to axillary ultrasound for differentiating between no, limited and advanced axillary nodal disease in newly diagnosed breast cancer patients. Eur J Radiol. 2016;85:2288\u201394. \nhttps:\/\/doi.org\/10.1016\/j.ejrad.2016.10.030\n\n.","journal-title":"Eur J Radiol"},{"key":"3823_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s13244-015-0404-2","volume":"6","author":"VJ Kuijs","year":"2015","unstructured":"Kuijs VJ, Moossdorff M, Schipper RJ, Beets-Tan RG, Heuts EM, Keymeulen KB, et al. The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review. Insights Imaging. 2015;6:203\u201315. \nhttps:\/\/doi.org\/10.1007\/s13244-015-0404-2\n\n.","journal-title":"Insights Imaging"},{"key":"3823_CR8","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10549-012-2179-1","volume":"135","author":"BB Koolen","year":"2012","unstructured":"Koolen BB, Valdes Olmos RA, Elkhuizen PH, Vogel WV, Vrancken Peeters MJ, Rodenhuis S, et al. Locoregional lymph node involvement on 18F-FDG PET\/CT in breast cancer patients scheduled for neoadjuvant chemotherapy. Breast Cancer Res Treat. 2012;135:231\u201340. \nhttps:\/\/doi.org\/10.1007\/s10549-012-2179-1\n\n.","journal-title":"Breast Cancer Res Treat"},{"key":"3823_CR9","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1148\/radiol.14140090","volume":"273","author":"MW Huellner","year":"2014","unstructured":"Huellner MW, Appenzeller P, Kuhn FP, Husmann L, Pietsch CM, Burger IA, et al. Whole-body nonenhanced PET\/MR versus PET\/CT in the staging and restaging of cancers: preliminary observations. Radiology. 2014;273:859\u201369. \nhttps:\/\/doi.org\/10.1148\/radiol.14140090\n\n.","journal-title":"Radiology"},{"key":"3823_CR10","unstructured":"NABON. National breast cancer guideline, Oncoline. 2012. \nwww.oncoline.nl\/breastcancer\n\n. Accessed 17 May 2017."},{"key":"3823_CR11","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1148\/radiol.10100296","volume":"257","author":"CH Neal","year":"2010","unstructured":"Neal CH, Daly CP, Nees AV, Helvie MA. Can preoperative axillary US help exclude N2 and N3 metastatic breast cancer? Radiology. 2010;257:335\u201341. \nhttps:\/\/doi.org\/10.1148\/radiol.10100296\n\n.","journal-title":"Radiology"},{"key":"3823_CR12","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00259-014-2961-x","volume":"42","author":"R Boellaard","year":"2015","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328\u201354. \nhttps:\/\/doi.org\/10.1007\/s00259-014-2961-x\n\n.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3823_CR13","doi-asserted-by":"publisher","first-page":"W641","DOI":"10.2214\/AJR.10.4889","volume":"196","author":"PA Baltzer","year":"2011","unstructured":"Baltzer PA, Dietzel M, Burmeister HP, Zoubi R, Gajda M, Camara O, et al. Application of MR mammography beyond local staging: is there a potential to accurately assess axillary lymph nodes? Evaluation of an extended protocol in an initial prospective study. AJR Am J Roentgenol. 2011;196:W641\u20137. \nhttps:\/\/doi.org\/10.2214\/AJR.10.4889\n\n.","journal-title":"AJR Am J Roentgenol"},{"key":"3823_CR14","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.ejrad.2010.10.005","volume":"80","author":"N Farshchian","year":"2011","unstructured":"Farshchian N, Tamari S, Farshchian N, Madani H, Rezaie M, Mohammadi-Motlagh HR. Diagnostic value of chemical shift artifact in distinguishing benign lymphadenopathy. Eur J Radiol. 2011;80:594\u20137. \nhttps:\/\/doi.org\/10.1016\/j.ejrad.2010.10.005\n\n.","journal-title":"Eur J Radiol"},{"key":"3823_CR15","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s00261-012-9957-4","volume":"38","author":"DM Lambregts","year":"2013","unstructured":"Lambregts DM, Heijnen LA, Maas M, Rutten IJ, Martens MH, Backes WH, et al. Gadofosveset-enhanced MRI for the assessment of rectal cancer lymph nodes: predictive criteria. Abdom Imaging. 2013;38:720\u20137. \nhttps:\/\/doi.org\/10.1007\/s00261-012-9957-4\n\n.","journal-title":"Abdom Imaging"},{"key":"3823_CR16","doi-asserted-by":"publisher","first-page":"3205","DOI":"10.1016\/j.ejca.2010.07.034","volume":"46","author":"TS Aukema","year":"2010","unstructured":"Aukema TS, Straver ME, Peeters MJ, Russell NS, Gilhuijs KG, Vogel WV, et al. Detection of extra-axillary lymph node involvement with FDG PET\/CT in patients with stage II-III breast cancer. Eur J Cancer. 2010;46:3205\u201310. \nhttps:\/\/doi.org\/10.1016\/j.ejca.2010.07.034\n\n.","journal-title":"Eur J Cancer"},{"key":"3823_CR17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.6004\/jnccn.2016.0037","volume":"14","author":"WJ Gradishar","year":"2016","unstructured":"Gradishar WJ, Anderson BO, Balassanian R, Blair SL, Burstein HJ, Cyr A, et al. Invasive breast cancer version 1.2016, NCCN clinical practice guidelines in oncology. J Natl Compr Cancer Netw. 2016;14:324\u201354.","journal-title":"J Natl Compr Cancer Netw"},{"key":"3823_CR18","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1097\/SLA.0000000000001863","volume":"264","author":"AE Giuliano","year":"2016","unstructured":"Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, et al. Locoregional recurrence after sentinel lymph node dissection with or without Axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 randomized trial. Ann Surg. 2016;264:413\u201320. \nhttps:\/\/doi.org\/10.1097\/SLA.0000000000001863\n\n.","journal-title":"Ann Surg"},{"key":"3823_CR19","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.ejso.2016.10.012","volume":"43","author":"SC Teixeira","year":"2017","unstructured":"Teixeira SC, Koolen BB, Elkhuizen PH, Vrancken Peeters MT, Stokkel MP, Rodenhuis S, et al. PET\/CT with 18F-FDG predicts short-term outcome in stage II\/III breast cancer patients upstaged to N2\/3 nodal disease. Eur J Surg Oncol. 2017;43:625\u201335. \nhttps:\/\/doi.org\/10.1016\/j.ejso.2016.10.012\n\n.","journal-title":"Eur J Surg Oncol"},{"key":"3823_CR20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/RLI.0000000000000197","volume":"50","author":"J Grueneisen","year":"2015","unstructured":"Grueneisen J, Nagarajah J, Buchbender C, Hoffmann O, Schaarschmidt BM, Poeppel T, et al. Positron emission tomography\/magnetic resonance imaging for local tumor staging in patients with primary breast cancer: a comparison with positron emission tomography\/computed tomography and magnetic resonance imaging. Investig Radiol. 2015;50:505\u201313. \nhttps:\/\/doi.org\/10.1097\/RLI.0000000000000197\n\n.","journal-title":"Investig Radiol"},{"key":"3823_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1148\/radiol.2016151155","volume":"281","author":"AN Melsaether","year":"2016","unstructured":"Melsaether AN, Raad RA, Pujara AC, Ponzo FD, Pysarenko KM, Jhaveri K, et al. Comparison of whole-body (18)F FDG PET\/MR imaging and whole-body (18)F FDG PET\/CT in terms of lesion detection and radiation dose in patients with breast cancer. Radiology. 2016;281:193\u2013202. \nhttps:\/\/doi.org\/10.1148\/radiol.2016151155\n\n.","journal-title":"Radiology"},{"key":"3823_CR22","doi-asserted-by":"publisher","first-page":"e181","DOI":"10.1097\/RLU.0000000000001101","volume":"41","author":"SC Teixeira","year":"2016","unstructured":"Teixeira SC, Koolen BB, Vogel WV, Wesseling J, Stokkel MP, Vrancken Peeters MJ, et al. Additional prone 18F-FDG PET\/CT acquisition to improve the visualization of the primary tumor and regional lymph node metastases in stage II\/III breast cancer. Clin Nucl Med. 2016;41:e181\u20136. \nhttps:\/\/doi.org\/10.1097\/RLU.0000000000001101\n\n.","journal-title":"Clin Nucl Med"},{"key":"3823_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1111\/tbj.12569","volume":"22","author":"AC Pujara","year":"2016","unstructured":"Pujara AC, Raad RA, Ponzo F, Wassong C, Babb JS, Moy L, et al. Standardized uptake values from PET\/MRI in metastatic breast cancer: an organ-based comparison with PET\/CT. Breast J. 2016;22:264\u201373. \nhttps:\/\/doi.org\/10.1111\/tbj.12569\n\n.","journal-title":"Breast J"},{"key":"3823_CR24","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.ejrad.2013.11.002","volume":"83","author":"L Pace","year":"2014","unstructured":"Pace L, Nicolai E, Luongo A, Aiello M, Catalano OA, Soricelli A, et al. Comparison of whole-body PET\/CT and PET\/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues. Eur J Radiol. 2014;83:289\u201396. \nhttps:\/\/doi.org\/10.1016\/j.ejrad.2013.11.002\n\n.","journal-title":"Eur J Radiol"},{"key":"3823_CR25","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.ejrad.2015.12.010","volume":"85","author":"LM Sawicki","year":"2016","unstructured":"Sawicki LM, Grueneisen J, Schaarschmidt BM, Buchbender C, Nagarajah J, Umutlu L, et al. Evaluation of (18)F-FDG PET\/MRI, (18)F-FDG PET\/CT, MRI, and CT in whole-body staging of recurrent breast cancer. Eur J Radiol. 2016;85:459\u201365. \nhttps:\/\/doi.org\/10.1016\/j.ejrad.2015.12.010\n\n.","journal-title":"Eur J Radiol"},{"key":"3823_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1524-4741.2010.00987.x","volume":"16","author":"I Segaert","year":"2010","unstructured":"Segaert I, Mottaghy F, Ceyssens S, De Wever W, Stroobants S, Van Ongeval C, et al. Additional value of PET-CT in staging of clinical stage IIB and III breast cancer. Breast J. 2010;16:617\u201324. \nhttps:\/\/doi.org\/10.1111\/j.1524-4741.2010.00987.x\n\n.","journal-title":"Breast J"},{"key":"3823_CR27","doi-asserted-by":"publisher","first-page":"4746","DOI":"10.1200\/JCO.2008.17.1496","volume":"26","author":"D Fuster","year":"2008","unstructured":"Fuster D, Duch J, Paredes P, Velasco M, Munoz M, Santamaria G, et al. Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography\/computed tomography compared with conventional imaging procedures. J Clin Oncol. 2008;26:4746\u201351. \nhttps:\/\/doi.org\/10.1200\/JCO.2008.17.1496\n\n.","journal-title":"J Clin Oncol"},{"key":"3823_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1093\/annonc\/mdl425","volume":"18","author":"U Veronesi","year":"2007","unstructured":"Veronesi U, De Cicco C, Galimberti VE, Fernandez JR, Rotmensz N, Viale G, et al. A comparative study on the value of FDG-PET and sentinel node biopsy to identify occult axillary metastases. Ann Oncol. 2007;18:473\u20138. \nhttps:\/\/doi.org\/10.1093\/annonc\/mdl425\n\n.","journal-title":"Ann Oncol"},{"key":"3823_CR29","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.2214\/AJR.15.15371","volume":"206","author":"SC Teixeira","year":"2016","unstructured":"Teixeira SC, Rebolleda JF, Koolen BB, Wesseling J, Jurado RS, Stokkel MP, et al. Evaluation of a hanging-breast PET system for primary tumor visualization in patients with stage I-III breast cancer: comparison with standard PET\/CT. AJR Am J Roentgenol. 2016;206:1307\u201314. \nhttps:\/\/doi.org\/10.2214\/AJR.15.15371\n\n.","journal-title":"AJR Am J Roentgenol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3823-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3823-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,12,27]],"date-time":"2017-12-27T22:57:11Z","timestamp":1514415431000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3823-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,14]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["3823"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3823-0","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,14]]}}}